Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Pfizer claims new series for BPH with selective prostatic alpha1-adrenoceptor-antagonist effects

Dec. 1, 1998

Japanese researchers present positive findings in Synsorb Pk trial

Nov. 27, 1998

New treatment for aldosterone-related disorders discovered by French research team

Nov. 24, 1998

Dual 5alpha-reductase inhibitors and alpha1-blocking agents prepared at Zeria

Nov. 23, 1998

Agents for nephritis in the Tsumura pipeline

Nov. 19, 1998

Dutasteride outshines finasteride in BPH Rx

Nov. 18, 1998

OPC-21268 improves glomerulonephritis in hypercholesterolemic rats, nephropathy in diabetic rats

Nov. 13, 1998

Vasopressin V2 receptor antagonist beneficial in mouse model of PKD

Nov. 13, 1998

VPA-985 characterized as potent, selective, orally active V2 antagonist

Nov. 13, 1998

Sepracor announces results of phase II pilot trial for (S)-oxybutynin

Nov. 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...